Working to gain an insight into the mechanisms driving tumorigenesis, drug resistance, metastasis, and to develop personalized targeted therapies and precision medicine to treat both drug resistance and metastasis. Learn more.
Working to develop rapid diagnostic methods for the determination of synergy or antagonism between two or more antimicrobial agents against multi-drug resistant bacteria and fungi. Learn more.
Working to identify novel and innovative approaches to diagnose and treat diseases of the nervous system. Learn more.
Working to seek a better understanding of treatment approaches for rheumatic diseases, creating an environment for rewarding creativity and learning for the next generation of rheumatologists, ultimately improving quality of service and patient outcomes. Learn more.
Working to (1) Increase recipient access to orthotopic liver transplantation (OLT) through identification and targeting critical mediators of tissue damage caused by ischemia/reperfusion (I/R) injury. (2) Identify (a) diagnostic biomarkers in hepatocellular carcinoma (HCC) for patients at high risk for metastasis and (b) HCC-mutation profiles which can predict therapeutic susceptibility and limit risk of recurrence after OLT. Learn more.
Working to understand the mechanisms involved in atherosclerotic plaque rupture because this is a critical barrier to developing new therapies for the prevention of carotid-related stroke and myocardial infarction (MI), both of which are complications of atherosclerosis. Learn more.
Working to identify novel therapeutic targets in diabetic kidney disease using gene based strategies. Learn more.